University of Mississippi Medical Center — Jackson, Mississippi

Public research footprint of University of Mississippi Medical Center, compiled from the ClinicalTrials.gov public registry.

1,147

Registered studies

279

Active

104

Recruiting now

676

Completed

152

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT00588770 — Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or… (Active Not Recruiting)
NCT03984448 — Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for… (Active Not Recruiting)
NCT05677100 — Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Mississippi Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.